Agenda Details

Learn more about sessions and presentations at the 26th Annual Meeting

Detailed Program

Tuesday, May 16 2023
01:30 PM – 03:15 PM PT

Pricing Considerations in Genetic Therapies - Reassessing Access and Privilege

The advent of fully commercialized gene and cell therapies in the last decade has prompted debates about pricing and access for the field. This symposium will first provide an overview of the core ethical questions at play, then engage a series of stakeholders to provide their views on the US healthcare system at large, unique development and pricing considerations for CGTs, and the question of privilege in patient access.

Session Details

01:30 PM – 03:15 PM - Room 502 AB

Co-Chair

David J. Segal. University of California, Davis, Davis, CA

01:30 PM – 03:15 PM - Room 502 AB

Co-Chair

Rachel Salzman, DVM. ALD Connect, Delray Beach, FL, Alcyone Therapeutics, Lowell, MA

01:31 PM – 01:45 PM - Room 502 AB

Setting the Stage: Outlining the Ethical Dilemmas Involved in Pricing and Access

Rachel Salzman, DVM. ALD Connect, Delray Beach, FL

01:45 PM – 02:00 PM - Room 502 AB

Pricing of and Access to Gene Therapies - Opportunities and Challenges

Sarah Emond, MPP. Institute for Clinical and Economical Review (ICER), Boston, MA

02:00 PM – 02:15 PM - Room 502 AB

Pricing and Valuation of CGTs from the Developer Perspective

Mary Lacey Reuther. CSL Behring, DC

02:15 PM – 02:30 PM - Room 502 AB

The Promise and Challenges of Accessing Innovative High-cost Therapies: Angelman Syndrome

Allyson Berent, DVM, DACVIM. Foundation for Angelman Syndrome Therapeutics, New York, NY

02:30 PM – 02:45 PM - Room 502 AB

Assessing the American Health Care System: How Did We Get Here?

Aaron Seth Kesselheim. Brigham and Women's Hospital, MA

02:45 PM – 03:15 PM - Room 502 AB

Panelist

Rachel Salzman, DVM. ALD Connect, Delray Beach, FL, Alcyone Therapeutics, Lowell, MA

02:45 PM – 03:15 PM - Room 502 AB

Panelist

Mary-Lacey Reuther. , DC

02:45 PM – 03:15 PM - Room 502 AB

Panelist

Sarah Emond, MPP. Institute for Clinical and Economical Review (ICER), Boston, MA

02:45 PM – 03:15 PM - Room 502 AB

Panelist

Allyson Berent, DVM, DACVIM. Foundation for Angelman Syndrome Therapeutics, New York, NY

© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy. 

Kentico CMS Development by Reason One | Powered by Kentico

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.